Immunological aspects of HTLV-1 persistence; for the prevention and treatment of Adult T-cell leukaemia-lymphoma (ATL).

Weterings DA, Rowan AG, Cook LB

Open source

DOI
10.1016/j.leukres.2024.107635
Published
2025 Jan
Container
Leukemia research
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.leukres.2024.107635,
  title = {Immunological aspects of HTLV-1 persistence; for the prevention and treatment of Adult T-cell leukaemia-lymphoma (ATL).},
  author = {Weterings DA and Rowan AG and Cook LB},
  year = {2025},
  journal = {Leukemia research},
  doi = {10.1016/j.leukres.2024.107635},
  url = {https://doi.org/10.1016/j.leukres.2024.107635}
}

RIS

TY  - JOUR
TI  - Immunological aspects of HTLV-1 persistence; for the prevention and treatment of Adult T-cell leukaemia-lymphoma (ATL).
AU  - Weterings DA
AU  - Rowan AG
AU  - Cook LB
PY  - 2025
JO  - Leukemia research
DO  - 10.1016/j.leukres.2024.107635
UR  - https://doi.org/10.1016/j.leukres.2024.107635
ER  - 

APA

DA, W., AG, R., & LB, C. (2025). Immunological aspects of HTLV-1 persistence; for the prevention and treatment of Adult T-cell leukaemia-lymphoma (ATL).. Leukemia research. https://doi.org/10.1016/j.leukres.2024.107635

Source records